Nkarta (NKTX) Stock Price, Quote, News & History | Benzinga

Nkarta Inc (NKTX) Stock Price, Quote, News & History

NKTXNASDAQ

Trade with Public

Trade with Public

$2.67

-0.095-3.44%

Last update: Aug 31, 3:06 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.73

Close

-

Volume / Avg.

203.55K / 643.89K

Day Range

$2.65 - $2.75

52 Wk Range

1.70 - 3.72

Market Cap

$190.88M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

6.28%

Days to Cover

6.25

Recent Nkarta, Inc. News

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space

Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.

Vandana Singh

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Avi Kapoor

Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?

Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.

Vandana Singh

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month

Avi Kapoor

UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-92.76M

Investing Cash Flow (TTM)

63.55M

Financing Cash Flow (TTM)

746.00K

Free Cash Flow (TTM)

-93.90M

Capital Expenditure (TTM)

-1.15M

Net Change in Cash (TTM)

-28.46M

Analyst Trends and Forecast

2

Mar

1

May

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$89.18M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.80

Earnings Yield % (TTM)

-57.40%

Earnings Yield % (FWD)

-67.15%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.46

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$24.96M

Debt to Equity

0.30

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.73

Close

-

Volume / Avg.

203.55K / 643.89K

Day Range

$2.65 - $2.75

52 Wk Range

1.70 - 3.72

Market Cap

$190.88M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

6.28%

Days to Cover

6.25

About

Sector

Health Care

Industry

Biotechnology

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Nkarta (NKTX) stock?

A

You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nkarta (NKTX) competitors?

A

Other companies in Nkarta’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Nkarta (NKTX) stock?

A

Nkarta has a consensus price target of $13.00.

Q

What is the current price for Nkarta (NKTX)?

A

The stock price for Nkarta (NASDAQ: NKTX) is $2.665 last updated August 31, 2026 at 3:06 PM EDT.

Q

Does Nkarta (NKTX) pay a dividend?

A

There are no upcoming dividends for Nkarta.

Q

When is Nkarta (NASDAQ:NKTX) reporting earnings?

A

Nkarta does not have any upcoming earnings scheduled.

Q

Is Nkarta (NKTX) going to split?

A

There is no upcoming split for Nkarta.

Q

What sector and industry does Nkarta (NKTX) operate in?

A

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.